Pot stocks too expensive, says ‘dean of valuation’

Pot stocks too expensive, says ‘dean of valuation’

Aswath Damodaran, NYU Stern Faculty of Industry, on the affect of the Canadian marijuana legalization match. With CNBC’s Aditi Roy and Melissa Lee, and the Immediate Cash traders, Tim Seymour,…

Senate hearing on cannabis trade and banking challenges – 07/23/2019

Senate hearing on cannabis trade and banking challenges – 07/23/2019

The Senate Banking, Housing and Urban Affairs Committee holds a hearing on cannabis trade and banking challenges. » Subscribe to CNBC TV: n» Subscribe to CNBC: C» Subscribe to CNBC…

Tilray CEO Brendan Kennedy on hashish industry

Tilray CEO Brendan Kennedy on hashish industry

CNBC’s “Energy Lunch” crew talks with Tilray CEO Brendan Kennedy about the expansion of the firm, the acquisition of Manitoba, and where the marketplace for hemp and CBD is headed….

There is a sizzling contemporary ETF that will perhaps enable you to play the cannabis dwelling

There is a sizzling contemporary ETF that will perhaps enable you to play the cannabis dwelling

CNBC’s Bob Pisani breaks down YOLO, a 2nd marijuana-themed ETF that ultimate hit the market. Dave Nadig of ETF.com and Cantor Fitzgerald’s Reggie Brown weigh in.

Tilray CEO Irwin Simon: We’re correctly positioned no subject full U.S. legality of cannabis

Tilray CEO Irwin Simon: We’re correctly positioned no subject full U.S. legality of cannabis

Tilray CEO Irwin Simon joins ‘Dispute on the Avenue’ to discuss the firm’s quarterly earnings outcomes, whether or not investors perceive the firm’s growth yarn, and where the firm is…

Curaleaf Government Chairman: I feel we’re gonna accumulate a lag bipartisan vote from the Senate

Curaleaf Government Chairman: I feel we’re gonna accumulate a lag bipartisan vote from the Senate

Boris Jordan, Curaleaf govt chairman, joins ‘Immediate Money’ to discuss day after nowadays’s vote on the senate banking committee concerning cannabis companies banking privileges. For accumulate entry to to are…

Cronos deal presents Altria a world cannabis platform, says analyst

Cronos deal presents Altria a world cannabis platform, says analyst

CNBC’s “Vitality Lunch” workforce discusses Altria’s investment in cannabis firm Cronos with Christopher Growe, an analyst at Stifel.

Present stays severe factors for cannabis companies, says analyst

Present stays severe factors for cannabis companies, says analyst

Vivien Azer, Cowen senior analyst and managing director, discusses her views on the cannabis sector sooner than Canada’s legalization.

Cannabis stocks driving excessive

Cannabis stocks driving excessive

CNBC’s Dominic Chu takes a behold at the ETFs that consist of crimson-sizzling pot stocks.

Unique Tilray CEO discusses constructing a global cannabis impress

Unique Tilray CEO discusses constructing a global cannabis impress

Tilray shareholders voted to approve the merger with Aphria. Unique Tilray CEO Irwin Simon joins ‘Closing Bell’ to protest about the outlook of the cannabis impress. For catch entry to…